11 results
8-K
EX-5.1
MLYS
Mineralys Therapeutics Inc
31 May 24
Financial Statements and Exhibits
4:06pm
of the Company as to the accuracy of such factual matters, in each case without independent verification thereof or other investigation. We have … assumed, without investigation, the following: (a) the genuineness of signatures, including electronic signatures, appearing upon the certifications
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
, proceeding, inquiry or investigation before or brought by any Governmental Entity now pending or, to the knowledge of the Company, threatened, against … of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or U.S. or non
S-3
EX-4.3
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
.
7.2.7The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument … , but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit.
7.2.8The Trustee shall
S-3
EX-5.1
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
verification thereof or other investigation. We have assumed, without investigation, the following: (a) the genuineness of signatures, including
8-K
EX-10.1
8rysa
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
DRS/A
0ti9ldd0ot 1b
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
kzntgh9c 21ljzcjj
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
EX-10.9
k81y vwf3jj
4 Nov 22
Draft registration statement
12:00am
DRS
n2n5q0hc4ja
4 Nov 22
Draft registration statement
12:00am
DRS
EX-3.2
o8r4 wd7mgiiz
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next